Apple stock price target cut on lower iPhone sales outlook

Apple Inc.’s stock price target was cut at Pacific Crest, which cited “stable, but uninspiring” demand for the technology giant’s new iPhones. Analyst Andy Hargreaves kept his rating at overweight, saying the stock is still “too cheap,” but trimmed his price target to $127, or 16% above Friday’s closing price of $109.90, frmo $129. “While we believe Apple has slightly reduced its forecast to suppliers, the change is not drastic and is mostly a return to forecasts in place prior to an increase in October,” Hargreaves wrote in a note to clients. Still he cut, his estimate for fiscal first-quarter iPhone sales to 76.8 million units from 78.3 million, and his fiscal 2017 estimate to 225.0 million from 231.9 million. Hargreaves slashed his fiscal 2017 earnings-per-share outlook to $8.58 from $8.94, compared with the FactSet consensus of $9.00. He said he believes the iPhone estimate changes, recent currency moves, concerns over trade policy and the potential for costs in the next iPhone cycle to increase all pose threats to gross margins. “This is likely to act as an overhang that reduces optimism around near-term upside potential,” Hargreaves said. The stock, which edged up 0.3% in premarket trade, has lost 1% since the election through Friday, while the Dow Jones Industrial Average has rallied 4.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

OncoMed says CMO Dupont has resigned and expects return to Genentech/Roche

OncoMed Pharmaceuticals Inc. said early Monday that Chief Medical Officer Jakob Dupont had resigned, effective early 2017, and that he plans a return to Genentech/Roche . The company said it has started a search for its next CMO. Dupont’s resignation was due to “personal and family-related issues,” OncoMed said. Dupont worked at Roche, and before that Genentech, for about five years, according to his LinkedIn profile, and his return to the company should be “a position of significant responsibility in oncology clinical development,” OncoMed said. OncoMed shares, which were not active in pre-market trade, dropped 62.4% year-to-date to $8.48 per share, compared with a 7.2% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Cerecor Inc. shares drop 37% after midstage trial failure

Cerecor Inc. shares dropped 37% in pre-market trade Monday after the company said its midstage clinical trial for a nicotine withdrawal treatment failed to meet its primary objective. The company is also developing the CERC-501 treatment for Major Depressive Disorder, which it said it will continue to do. The biotech, which was valued at $1.75 at Friday’s close, saw shares sink 47.8% year-to-date, compared with a 7.2% rise in the S&P 500 .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Hilton board approves spinoff of Park Hotels and timeshare businesses

Hilton Worldwide Holdings Inc. said Monday its board has approved the spinoff of its Park Hotels & Resorts and its Hilton Grand Vacations timeshare business. The company said its shareholders will receive 2 shares of Park and one share of HGV for every 10 shares of Hilton that they own. Following the distribution, the company will conduct a 1-for-3 reverse stock split. The transactions are expected to be completed on Jan. 3, 2017. Park and HGV will begin regular trading on the New York Stock Exchange under the ticker symbols “PK” and “HGV” on Jan. 4. Hilton shares were up about 1% in premarket trade, and have gained 18% in the year so far, while the S&P 500 has gained 7.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Johnson Controls sets targets for fiscal 2017 and beyond

Johnson Controls Inc. , which completed its merger with Tyco in September, on Monday set targets for fiscal 2017 and beyond, setting guidance for adjusted per-share earnings at $2.60 to $2.75, compared with a pro forma adjusted EPS of $2.31 for fiscal 2016. “We are well positioned as a market leader to accelerate growth in our core buildings and energy businesses,” Chief Executive Alex Molinaroli said in a statement. The industrial company is targeting fiscal 2020 adjusted EPS growth of 12% to 15%. It is targeting an organic revenue compound average growth rate of 3% to 4%, including $500 million in run-rate sales synergies, it said. It expects EBIT growth of 40% to 55% before special items, with 300 to 380 basis points of margin expansion. Shares were not yet active in premarket trade, but are up 52% in the year to date, while the S&P 500 has gained 7.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Consolidated Communications to buy FairPoint in a $1.5 billion stock and debt deal

Consolidated Communications Inc. announced Monday an agreement to buy FairPoint Communications Inc. in an all-stock deal valued at $1.5 billion, including debt. Under terms of the deal, FairPoint shareholders will receive 0.7300 Consolidated shares for each FairPoint share they own. Based on Friday’s closing prices, that values FairPoint shares at $20.72, or a 22% premium and implied a market value for FairPoint of $560.9 million. The deal, which is expected to close by mid 2017, is expected to generate annual synergies of $55 million, and should added to cash flow per share in the first year. “The financial benefits associated with the combination in the form of synergies and reduced leverage provide us additional operating and strategic flexibility going forward,” said Consolidated Chief Executive Bob Udell. The stocks are still halted for news until 7:30 a.m. ET. FairPoint shares have gained 5.8% year to date through Friday, while Consolidated’s stock has run up 35% and the S&P 500 has tacked on 7.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Trump taps former rival Ben Carson to be housing secretary

President-elect Donald Trump will nominate Ben Carson to lead the Department of Housing and Urban Development, Trump’s transition team said Monday morning. Carson ran against Trump in the Republican presidential primaries, and is a retired neurosurgeon. Last month, Carson’s business manager and close friend Armstrong Williams told the Hill that Carson informed Trump he wasn’t interested in the position. “Dr. Carson feels he has no government experience, he’s never run a federal agency,” Williams told the Hill.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Italian bond yields jump back above 2% after ‘no’ vote

Borrowing costs in Italy jumped on Monday after voters rejected Prime Minister Matteo Renzi’s proposals for constitutional reforms. Renzi said he will officially resign on Monday, which some worry will put to put the populist and eurosceptic 5 Star Movement on a path to more power and lead Italy out of the eurozone. The yield on 10-year Italian government rose 11 basis points to 2.020% in early Monday trade. To cope with the immediate market volatility, the European Central Bank could temporarily tilt its bond buying toward more Italian debt, analysts said. The ECB meets on Thursday.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

S&P raises Prologis’s rating to ‘A-‘ on solid performance

S&P Global Ratings on Friday raised Prologis Inc.’s rating to A- from BBB+, citing its diversified real estate portfolio and potential for rent growth. “Prologis’ financial policies have supported debt reduction, and we think this approach will continue,” said S&P Global in a statement. The outlook on the rating is stable. Prologis is a real estate investment trust headquartered in San Francisco.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Zendesk shares fall after exec resignations announced

Shares of Zendesk Inc. fell in the extended session Friday after the cloud-based software company announced the departure of a pair of its executives. Zendesk shares declined 5.5% to $20 after hours. In a Securities and Exchange Commission filing, the company said that Amanda Klein, senior vice president of Go to Market Strategy was resigning as of Dec. 30, and Marcus Bragg, senior vice president of worldwide sales, would leave Dec. 7 to pursue another position.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News